Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia
Naseema Gangat, Isla McKerrow Johnson, Kristen McCullough, Faiqa Farrukh, Aref Al‐Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek A. Mangaonkar, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi
Abstract
Not available.
Topics & Concepts
VenetoclaxHypomethylating agentMyeloid leukemiaMedicineMyeloidOncologyInternal medicineAzacitidineLeukemiaCancer researchImmunologyBiologyGeneticsGeneDNA methylationChronic lymphocytic leukemiaGene expressionAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment